Is Ys Biopharma Co Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: YS) stock is to Buy YS stock.
Out of 1 analyst, 0 (0%) are recommending YS as a Strong Buy, 1 (100%) are recommending YS as a Buy, 0 (0%) are recommending YS as a Hold, 0 (0%) are recommending YS as a Sell, and 0 (0%) are recommending YS as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year YS price target, the average YS price target is $5.25, with the highest YS stock price forecast at $5.25 and the lowest YS stock price forecast at $5.25.
The Wall Street analyst predicted that Ys Biopharma Co's share price could reach $5.25 by Nov 13, 2024. The average Ys Biopharma Co stock price prediction forecasts a potential upside of 756.44% from the current YS share price of $0.61.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.